NCT07034261View on ClinicalTrials.gov

Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes

NANot yet recruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions

Gestational Diabetes

Interventions

DEVICE

Blinded Continuous Glucose Monitoring Device

Subjects will be asked to wear blinded continuous glucose monitoring device for 14 days.

All Listed Sponsors

lead

University of Chicago

OTHER